Upper gastrointestinal involvement in paediatric onset Crohn's disease: Prevalence and clinical implications

S. Crocco, S. Martelossi, N. Giurici, V. Villanacci, A. Ventura

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Background and aims: Our study evaluated the prevalence, the characteristics and implications of the upper gastrointestinal localisation (UGI+) in paediatric Crohn's Disease (CD) patients. Methods: This prospective study evaluated 45 newly diagnosed CD patients at diagnosis and follow up with respect to CD localisation. Results: All patients presented CD at the colon and/or ileum. In 24/45 patients (53.3%, 12 F and 12 M) an UGI+ involvement was also found. UGI+ patients had a younger age of onset (10.9. years versus 12.6. years; P <0.05). PCDAI at diagnosis was significantly higher in the UGI+ (41 vs 25 P <0.01). UGI+ patients were overall more symptomatic. Pancolitis and extraintestinal manifestations were also more frequent (19/24 (80%) vs. 12/21 (57%) P <0.01). Growth was more impaired at diagnosis in UGI+ patients. By the end of the follow-up (mean 3. years, range 2 to 4) no significant difference was found in PCDAI (17 in UGI+ patients vs. 11 in UGI- P = NS), or the number of relapses. Weight and growth catch-up in UGI+ patients were comparable to UGI- ones. However, UGI+ patients required a more aggressive therapeutic approach. Conclusion: At least half of paediatric onset CD patients have an upper gastrointestinal localisation. UGI+ patients present an earlier onset and a more severe disease. The final outcome does not differ, but UGI+ patients require a more aggressive therapeutic approach.

Original languageEnglish
Pages (from-to)51-55
Number of pages5
JournalJournal of Crohn's & colitis
Volume6
Issue number1
DOIs
Publication statusPublished - Feb 2012

Fingerprint

Crohn Disease
Pediatric Crohn's disease
Growth
Ileum
Age of Onset
Colon
Cross-Sectional Studies
Prospective Studies
Weights and Measures
Recurrence
Therapeutics

Keywords

  • Crohn's disease
  • Paediatric
  • Upper gastrointestinal involvement

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Upper gastrointestinal involvement in paediatric onset Crohn's disease : Prevalence and clinical implications. / Crocco, S.; Martelossi, S.; Giurici, N.; Villanacci, V.; Ventura, A.

In: Journal of Crohn's & colitis, Vol. 6, No. 1, 02.2012, p. 51-55.

Research output: Contribution to journalArticle

@article{ba8d4f16bd4b42cb9176926154ab659d,
title = "Upper gastrointestinal involvement in paediatric onset Crohn's disease: Prevalence and clinical implications",
abstract = "Background and aims: Our study evaluated the prevalence, the characteristics and implications of the upper gastrointestinal localisation (UGI+) in paediatric Crohn's Disease (CD) patients. Methods: This prospective study evaluated 45 newly diagnosed CD patients at diagnosis and follow up with respect to CD localisation. Results: All patients presented CD at the colon and/or ileum. In 24/45 patients (53.3{\%}, 12 F and 12 M) an UGI+ involvement was also found. UGI+ patients had a younger age of onset (10.9. years versus 12.6. years; P <0.05). PCDAI at diagnosis was significantly higher in the UGI+ (41 vs 25 P <0.01). UGI+ patients were overall more symptomatic. Pancolitis and extraintestinal manifestations were also more frequent (19/24 (80{\%}) vs. 12/21 (57{\%}) P <0.01). Growth was more impaired at diagnosis in UGI+ patients. By the end of the follow-up (mean 3. years, range 2 to 4) no significant difference was found in PCDAI (17 in UGI+ patients vs. 11 in UGI- P = NS), or the number of relapses. Weight and growth catch-up in UGI+ patients were comparable to UGI- ones. However, UGI+ patients required a more aggressive therapeutic approach. Conclusion: At least half of paediatric onset CD patients have an upper gastrointestinal localisation. UGI+ patients present an earlier onset and a more severe disease. The final outcome does not differ, but UGI+ patients require a more aggressive therapeutic approach.",
keywords = "Crohn's disease, Paediatric, Upper gastrointestinal involvement",
author = "S. Crocco and S. Martelossi and N. Giurici and V. Villanacci and A. Ventura",
year = "2012",
month = "2",
doi = "10.1016/j.crohns.2011.06.013",
language = "English",
volume = "6",
pages = "51--55",
journal = "Journal of Crohn's and Colitis",
issn = "1873-9946",
publisher = "Oxford University Press",
number = "1",

}

TY - JOUR

T1 - Upper gastrointestinal involvement in paediatric onset Crohn's disease

T2 - Prevalence and clinical implications

AU - Crocco, S.

AU - Martelossi, S.

AU - Giurici, N.

AU - Villanacci, V.

AU - Ventura, A.

PY - 2012/2

Y1 - 2012/2

N2 - Background and aims: Our study evaluated the prevalence, the characteristics and implications of the upper gastrointestinal localisation (UGI+) in paediatric Crohn's Disease (CD) patients. Methods: This prospective study evaluated 45 newly diagnosed CD patients at diagnosis and follow up with respect to CD localisation. Results: All patients presented CD at the colon and/or ileum. In 24/45 patients (53.3%, 12 F and 12 M) an UGI+ involvement was also found. UGI+ patients had a younger age of onset (10.9. years versus 12.6. years; P <0.05). PCDAI at diagnosis was significantly higher in the UGI+ (41 vs 25 P <0.01). UGI+ patients were overall more symptomatic. Pancolitis and extraintestinal manifestations were also more frequent (19/24 (80%) vs. 12/21 (57%) P <0.01). Growth was more impaired at diagnosis in UGI+ patients. By the end of the follow-up (mean 3. years, range 2 to 4) no significant difference was found in PCDAI (17 in UGI+ patients vs. 11 in UGI- P = NS), or the number of relapses. Weight and growth catch-up in UGI+ patients were comparable to UGI- ones. However, UGI+ patients required a more aggressive therapeutic approach. Conclusion: At least half of paediatric onset CD patients have an upper gastrointestinal localisation. UGI+ patients present an earlier onset and a more severe disease. The final outcome does not differ, but UGI+ patients require a more aggressive therapeutic approach.

AB - Background and aims: Our study evaluated the prevalence, the characteristics and implications of the upper gastrointestinal localisation (UGI+) in paediatric Crohn's Disease (CD) patients. Methods: This prospective study evaluated 45 newly diagnosed CD patients at diagnosis and follow up with respect to CD localisation. Results: All patients presented CD at the colon and/or ileum. In 24/45 patients (53.3%, 12 F and 12 M) an UGI+ involvement was also found. UGI+ patients had a younger age of onset (10.9. years versus 12.6. years; P <0.05). PCDAI at diagnosis was significantly higher in the UGI+ (41 vs 25 P <0.01). UGI+ patients were overall more symptomatic. Pancolitis and extraintestinal manifestations were also more frequent (19/24 (80%) vs. 12/21 (57%) P <0.01). Growth was more impaired at diagnosis in UGI+ patients. By the end of the follow-up (mean 3. years, range 2 to 4) no significant difference was found in PCDAI (17 in UGI+ patients vs. 11 in UGI- P = NS), or the number of relapses. Weight and growth catch-up in UGI+ patients were comparable to UGI- ones. However, UGI+ patients required a more aggressive therapeutic approach. Conclusion: At least half of paediatric onset CD patients have an upper gastrointestinal localisation. UGI+ patients present an earlier onset and a more severe disease. The final outcome does not differ, but UGI+ patients require a more aggressive therapeutic approach.

KW - Crohn's disease

KW - Paediatric

KW - Upper gastrointestinal involvement

UR - http://www.scopus.com/inward/record.url?scp=84855943519&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855943519&partnerID=8YFLogxK

U2 - 10.1016/j.crohns.2011.06.013

DO - 10.1016/j.crohns.2011.06.013

M3 - Article

C2 - 22261527

AN - SCOPUS:84855943519

VL - 6

SP - 51

EP - 55

JO - Journal of Crohn's and Colitis

JF - Journal of Crohn's and Colitis

SN - 1873-9946

IS - 1

ER -